Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Buy
67
IBBQ Quote, Financials, Valuation and Earnings
Last price:
$22.19
Seasonality move
:
-0.89%
Day range:
$21.91 - $22.26
52-week range:
$17.84 - $24.84
Dividend yield:
1.01%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
8.9K
Avg. volume:
8.8K
1-year change:
-8.39%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
-- | -- | -- | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
$21.92 | -- | -- | -- | $0.03 | 1.01% | -- |
|
BBH
VanEck Biotech ETF
|
$155.44 | -- | -- | -- | $1.25 | 0.81% | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
$24.84 | -- | -- | -- | $0.12 | 1.93% | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
$99.39 | -- | -- | -- | $0.06 | 0.35% | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
$67.13 | -- | -- | -- | $0.31 | 1.74% | -- |
|
IHF
iShares US Healthcare Providers ETF
|
$42.59 | -- | -- | -- | $0.06 | 1.05% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | 0.695 | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | 0.630 | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | 0.835 | -- | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
-- | 0.984 | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | 0.333 | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | 0.813 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
-- | -- | -- | -- | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- | -- |
Invesco Nasdaq Biotechnology ETF vs. Competitors
-
Which has Higher Returns IBBQ or BBH?
VanEck Biotech ETF has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat VanEck Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- BBHVanEck Biotech ETF-- -- -- -
What do Analysts Say About IBBQ or BBH?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than VanEck Biotech ETF, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than VanEck Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 BBHVanEck Biotech ETF0 0 0 -
Is IBBQ or BBH More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison VanEck Biotech ETF has a beta of 0.764, suggesting its less volatile than the S&P 500 by 23.586%.
-
Which is a Better Dividend Stock IBBQ or BBH?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 1.01%. VanEck Biotech ETF offers a yield of 0.81% to investors and pays a quarterly dividend of $1.25 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. VanEck Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or BBH?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than VanEck Biotech ETF quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than VanEck Biotech ETF's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while VanEck Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for VanEck Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- BBHVanEck Biotech ETF-- -- -- --
-
Which has Higher Returns IBBQ or FTXH?
First Trust Nasdaq Pharmaceuticals ETF has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat First Trust Nasdaq Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- -
What do Analysts Say About IBBQ or FTXH?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Nasdaq Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than First Trust Nasdaq Pharmaceuticals ETF, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than First Trust Nasdaq Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 FTXHFirst Trust Nasdaq Pharmaceuticals ETF0 0 0 -
Is IBBQ or FTXH More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.659, suggesting its less volatile than the S&P 500 by 34.143%.
-
Which is a Better Dividend Stock IBBQ or FTXH?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 1.01%. First Trust Nasdaq Pharmaceuticals ETF offers a yield of 1.93% to investors and pays a quarterly dividend of $0.12 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. First Trust Nasdaq Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or FTXH?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than First Trust Nasdaq Pharmaceuticals ETF quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than First Trust Nasdaq Pharmaceuticals ETF's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while First Trust Nasdaq Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for First Trust Nasdaq Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns IBBQ or FXH?
First Trust Health Care AlphaDEX Fund has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat First Trust Health Care AlphaDEX Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- FXHFirst Trust Health Care AlphaDEX Fund-- -- -- -
What do Analysts Say About IBBQ or FXH?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Health Care AlphaDEX Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than First Trust Health Care AlphaDEX Fund, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than First Trust Health Care AlphaDEX Fund.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 FXHFirst Trust Health Care AlphaDEX Fund0 0 0 -
Is IBBQ or FXH More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison First Trust Health Care AlphaDEX Fund has a beta of 0.785, suggesting its less volatile than the S&P 500 by 21.471%.
-
Which is a Better Dividend Stock IBBQ or FXH?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 1.01%. First Trust Health Care AlphaDEX Fund offers a yield of 0.35% to investors and pays a quarterly dividend of $0.06 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. First Trust Health Care AlphaDEX Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or FXH?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than First Trust Health Care AlphaDEX Fund quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than First Trust Health Care AlphaDEX Fund's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while First Trust Health Care AlphaDEX Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for First Trust Health Care AlphaDEX Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- FXHFirst Trust Health Care AlphaDEX Fund-- -- -- --
-
Which has Higher Returns IBBQ or IHE?
iShares US Pharmaceuticals ETF has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat iShares US Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- IHEiShares US Pharmaceuticals ETF-- -- -- -
What do Analysts Say About IBBQ or IHE?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than iShares US Pharmaceuticals ETF, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than iShares US Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 IHEiShares US Pharmaceuticals ETF0 0 0 -
Is IBBQ or IHE More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares US Pharmaceuticals ETF has a beta of 0.574, suggesting its less volatile than the S&P 500 by 42.647%.
-
Which is a Better Dividend Stock IBBQ or IHE?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 1.01%. iShares US Pharmaceuticals ETF offers a yield of 1.74% to investors and pays a quarterly dividend of $0.31 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. iShares US Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or IHE?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than iShares US Pharmaceuticals ETF quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than iShares US Pharmaceuticals ETF's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while iShares US Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for iShares US Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- IHEiShares US Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns IBBQ or IHF?
iShares US Healthcare Providers ETF has a net margin of -- compared to Invesco Nasdaq Biotechnology ETF's net margin of --. Invesco Nasdaq Biotechnology ETF's return on equity of -- beat iShares US Healthcare Providers ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBQInvesco Nasdaq Biotechnology ETF-- -- -- IHFiShares US Healthcare Providers ETF-- -- -- -
What do Analysts Say About IBBQ or IHF?
Invesco Nasdaq Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare Providers ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Nasdaq Biotechnology ETF has higher upside potential than iShares US Healthcare Providers ETF, analysts believe Invesco Nasdaq Biotechnology ETF is more attractive than iShares US Healthcare Providers ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBBQInvesco Nasdaq Biotechnology ETF0 0 0 IHFiShares US Healthcare Providers ETF0 0 0 -
Is IBBQ or IHF More Risky?
Invesco Nasdaq Biotechnology ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares US Healthcare Providers ETF has a beta of 0.729, suggesting its less volatile than the S&P 500 by 27.109%.
-
Which is a Better Dividend Stock IBBQ or IHF?
Invesco Nasdaq Biotechnology ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 1.01%. iShares US Healthcare Providers ETF offers a yield of 1.05% to investors and pays a quarterly dividend of $0.06 per share. Invesco Nasdaq Biotechnology ETF pays -- of its earnings as a dividend. iShares US Healthcare Providers ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBBQ or IHF?
Invesco Nasdaq Biotechnology ETF quarterly revenues are --, which are smaller than iShares US Healthcare Providers ETF quarterly revenues of --. Invesco Nasdaq Biotechnology ETF's net income of -- is lower than iShares US Healthcare Providers ETF's net income of --. Notably, Invesco Nasdaq Biotechnology ETF's price-to-earnings ratio is -- while iShares US Healthcare Providers ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Nasdaq Biotechnology ETF is -- versus -- for iShares US Healthcare Providers ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -- IHFiShares US Healthcare Providers ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
55
TLN alert for Jul 19
Talen Energy [TLN] is up 24.44% over the past day.
Sell
48
CRSP alert for Jul 19
CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.
Buy
83
SOC alert for Jul 19
Sable Offshore [SOC] is up 11.86% over the past day.
